Wellstone Announces New Director of Research and Development

Wellstone Announces New Director of Research and Development



DURHAM, N.C., June 20  /PRNewswire-FirstCall/ -- Wellstone Filters (OTC:WLSF)
(BULLETIN BOARD: WLSF)  announced today that Dr. David Hill, Ph.D. has been
promoted to Director of Research and Development.  Dr. Hill, currently a
research associate at the University of North Carolina, earned his Ph.D. from
Wake Forest University and has a strong background in biophysics.

At the University of North Carolina, Dr. Hill's research has been focused on
mucus clearance from in the respiratory tract. Previously, Dr. Hill has studied
the role of motor proteins in nerve cells and developed new types of
microscopy.

CEO L.J. Hand states "Given Dr. Hill's experience in both respiratory issues as
well as developing new technology, we are thrilled to have him as part of the
research team."

Wellstone believes that its patented filter formulation removes tars and
certain carcinogens, while providing better taste. However, any claim as to the
benefit of any Wellstone cigarette to be sold will be made within the
parameters prescribed by the Federal Trade Commission. Wellstone emphasizes
that NO cigarette is safe. This corporate communication by Wellstone is not
intended to induce any person to purchase Wellstone tobacco products.
Wellstone's patented "Purity Enhanced Filter" does NOT mean a Safer Cigarette.

ABOUT THE COMPANY

Wellstone Filters, Inc. has developed and patented filter material that targets
irritating toxins produced when tobacco is smoked without removing the
compounds thought to be associated with the pleasurable effects of smoking.
Wellstone seeks to promote material for cigarette filters that will enable
cigarette manufacturers to provide consumers with an equally enjoyable
cigarette with substantially fewer carcinogens.

For more information, please see http://www.wellstonefilters.com/ or call
Investor relations at 336-597-8331.

Note: Except for the historical information contained herein, this new release
contains forward-looking statements that involve substantial risks and
uncertainties. Among the factors that could cause actual results or timelines
to differ materially are risks associated with research and clinical
development, regulatory approvals, supply capabilities and reliance on third-
party manufacturers, product commercialization, competition, litigation, and
the other risk factors listed from time to time in reports filed by Wellstone
with the Securities and Exchange Commission, including but not limited to risks
described under the caption "Important Factors That May Affect Our Business,
Our Results of Operation and Our Stock Price." The forward-looking statements
contained in this news release represent judgments of the management of
Wellstone as of the date of this release. Wellstone and its managers and agents
undertake no obligation to publicly update any forward- looking statements 

DATASOURCE: Wellstone Filters



CONTACT: Investor Relations of Wellstone Filters, Inc., [phone]



Web site:  http://www.wellstonefilters.com/

http://www.lowertar.com/ 

Copyright